AHAmelia Weber Hall

Amelia Weber Hall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amelia Weber Hall has a total of 624 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    by Timothy N. Audam, Benjamin Schmandt, Yi Huang, Young Beum Cho, Mayank Murali, Rama Kaalia, Saaket Agrawal, Jinping Liu, Hongjie Shi, Yuan Zhou, et al.

    Summary: The 9p21.3 locus is the strongest genetic association with coronary artery disease (CAD), yet its causal mechanisms remain unresolved. We map the regulatory architecture of 9p21.3 in disease-relevant vascular cells, identifying 12 enhancers within the CAD risk haplotype that respond dynamically to inflammatory and metabolic stress in fibroblasts and smooth muscle cells. These activated states are enriched for CAD heritability, implicating stress-responsive vascular wall cells in disease pathophysiology. Dense CRISPRi tiling integrated with fine-mapping and genomic constraint across >500,000 individuals nominates MTAP as the effector gene, with rs1537371 as a likely causal variant. Perturbation and multi-modal analyses show that MTAP loss induces pro-fibrotic and angiogenic programs and sensitizes vascular cells to TGF- β –driven pathological transitions. Our findings reveal a vascular-specific enhancer network through which noncoding variation at 9p21.3 modulates CAD risk via MTAP —a previously unrecognized regulator of vascular remodeling located 269 kb from the risk haplotype. Highlights: 9p21.3 CAD risk locus harbors 12 functional enhancers active in vascular wall cell types CAD heritability is enriched in stressed vascular fibroblasts and smooth muscle cells High-resolution CRISPRi-MAC-seq maps 9p21.3 enhancer-gene and SNP-gene interactions MTAP identified as a causal effector gene regulated by 9p21.3 fine-mapped and constrained variants MTAP modulates TGF-β-driven pathological vascular cell transitions


  • Open Access

    The impact of common and rare genetic variants on bradyarrhythmia development

    by Lu-Chen Weng, Joel T. Rämö, Sean J. Jurgens, Shaan Khurshid, Mark Chaffin, Amelia Weber Hall, Valerie N. Morrill, Xin Wang, Victor Nauffal, Yan V. Sun, et al.

    To broaden our understanding of bradyarrhythmias and conduction disease, we performed common variant genome-wide association analyses in up to 1.3 million individuals and rare variant burden testing in 460,000 individuals for sinus node dysfunction (SND), distal conduction disease (DCD) and pacemaker (PM) implantation. We identified 13, 31 and 21 common variant loci for SND, DCD and PM, respectively. Four well-known loci (SCN5A/SCN10A, CCDC141, TBX20 and CAMK2D) were shared for SND and DCD, while others were more specific for SND or DCD. SND and DCD showed a moderate genetic correlation (rg = 0.63). Cardiomyocyte-expressed genes were enriched for contributions to DCD heritability. Rare-variant analyses implicated LMNA for all bradyarrhythmia phenotypes, SMAD6 and SCN5A for DCD and TTN, MYBPC3 and SCN5A for PM. These results show that variation in multiple genetic pathways (for example, ion channel function, cardiac developmental programs, sarcomeric structure and cellular homeostasis) appear critical to the development of bradyarrhythmias.


  • Open Access

    SHARE-seq protocol v2.2 adapted for Mortazavi Lab v1

    by Elisabeth Rebboah, Amelia Hall

    This protocol is an updated version of the SHARE-seq protocol as originally described by Ma et al. in Cell (2020): https://www.sciencedirect.com/science/article/pii/S0092867420312538. The updated protocol is used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. This version is slightly modified from Amelia Hall's Protocols.io SHARE-seq protocol: https://www.protocols.io/view/share-seq-protocol-v2-2-81wgbx1oylpk/v4 with the equipment and personnel in the Mortazavi lab at UCI in mind. Some wording is edited for clarity and some buffer volumes increased to allow for some slight excess. It is also written with our "standard" experimental design using 8 samples and 1 plate set. Briefly, SHARE-seq (Simultaneous High-throughput ATAC and RNA Expression with sequencing) is a method that simultaneously measures both chromatin accessibility (via ATAC-seq) and gene expression (via RNA-seq) at the single-nucleus level. Nuclei undergo Tn5 transposition to cleave open chromatin, followed by reverse transcription to capture mRNA, with a biotin tag added specifically to the mRNA molecules. The nuclei then undergo three rounds of combinatorial barcoding to label both the DNA fragments and mRNA within each nucleus. After barcoding, the nuclei are aliquoted into subpools and lysed. Biotin-tagged mRNA is pulled out using magnetic streptavidin beads, while the ATAC fragments remain in solution. Library preparation continues with PCR amplification, cleanup, second-strand synthesis (for RNA libraries), and final subpool-level indexing before sequencing. The products of this protocol are two separate sets of single-nucleus ATAC-seq and RNA-seq libraries ready for sequencing on an Illumina sequencer.

  • Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias

    by Lu-Chen Weng, Shaan Khurshid, Amelia Weber Hall, Victor Nauffal, Valerie N. Morrill, Yan V. Sun, Joel T. Rämö, Dominik Beer, Simon Lee, Girish Nadkarni, et al.

    BACKGROUND: Substantial data support a heritable basis for supraventricular tachycardias, but the genetic determinants and molecular mechanisms of these arrhythmias are poorly understood. We sought to identify genetic loci associated with atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular accessory pathways or atrioventricular reciprocating tachycardia (AVAPs/AVRT). METHODS: We performed multiancestry meta-analyses of genome-wide association studies to identify genetic loci for AVNRT (4 studies) and AVAP/AVRT (7 studies). We assessed evidence supporting the potential causal effects of candidate genes by analyzing relations between associated variants and cardiac gene expression, performing transcriptome-wide analyses, and examining prior genome-wide association studies. RESULTS: Analyses comprised 2384 AVNRT cases and 106 489 referents, and 2811 AVAP/AVRT cases and 1,483 093 referents. We identified 2 significant loci for AVNRT, which implicate NKX2-5 and TTN as disease susceptibility genes. A transcriptome-wide association analysis supported an association between reduced predicted cardiac expression of NKX2-5 and AVNRT. We identified 3 significant loci for AVAP/AVRT, which implicate SCN5A , SCN10A , and TTN/CCDC141 . Variant associations at several loci have been previously reported for cardiac phenotypes, including atrial fibrillation, stroke, Brugada syndrome, and electrocardiographic intervals. CONCLUSIONS: Our findings highlight gene regions associated with ion channel function (AVAP/AVRT), as well as cardiac development and the sarcomere (AVAP/AVRT and AVNRT) as important potential effectors of supraventricular tachycardia susceptibility.


  • Open Access

    Transcriptional profile of the rat cardiovascular system at single cell resolution

    by Alessandro Arduini, Stephen J. Fleming, Ling Xiao, Amelia W. Hall, Amer-Denis Akkad, Mark Chaffin, Kayla J. Bendinelli, Nathan R. Tucker, Irinna Papangeli, Helene Mantineo, et al.

    Background: Despite the critical role of the cardiovascular system, our understanding of its cellular and transcriptional diversity remains limited. We therefore sought to characterize the cellular composition, phenotypes, molecular pathways, and communication networks between cell types at the tissue and sub-tissue level across the cardiovascular system of the healthy Wistar rat, an important model in preclinical cardiovascular research. We obtained high quality tissue samples under controlled conditions that reveal a level of cellular detail so far inaccessible in human studies. Methods and Results: We performed single nucleus RNA-sequencing in 78 samples in 10 distinct regions including the four chambers of the heart, ventricular septum, sinoatrial node, atrioventricular node, aorta, pulmonary artery, and pulmonary veins (PV), which produced an aggregate map of 505,835 nuclei. We identified 26 distinct cell types and additional subtypes, including a number of rare cell types such as PV cardiomyocytes and non-myelinating Schwann cells (NMSCs), and unique groups of vascular smooth muscle cells (VSMCs), endothelial cells (ECs) and fibroblasts (FBs), which gave rise to a detailed cell type distribution across tissues. We demonstrated differences in the cellular composition across different cardiac regions and tissue-specific differences in transcription for each cell type, highlighting the molecular diversity and complex tissue architecture of the cardiovascular system. Specifically, we observed great transcriptional heterogeneities among ECs and FBs. Importantly, several cell subtypes had a unique regional localization such as a subtype of VSMCs enriched in the large vasculature. We found the cellular makeup of PV tissue is closer to heart tissue than to the large arteries. We further explored the ligand-receptor repertoire across cell clusters and tissues, and observed tissue-enriched cellular communication networks, including heightened Nppa - Npr1 / 2 / 3 signaling in the sinoatrial node. Conclusions: Through a large single nucleus sequencing effort encompassing over 500,000 nuclei, we broadened our understanding of cellular transcription in the healthy cardiovascular system. The existence of tissue-restricted cellular phenotypes suggests regional regulation of cardiovascular physiology. The overall conservation in gene expression and molecular pathways across rat and human cell types, together with our detailed transcriptional characterization of each cell type, offers the potential to identify novel therapeutic targets and improve preclinical models of cardiovascular disease.


  • Open Access

    Nuclear Isolation and Purification Protocol for Single-Cell Methods v1

    by Guillermo Barreto Corona, Amelia Hall

    This protocol describes how to isolate and purify nuclei from solid tissue for use in single-cell library construction methods. The resulting nuclei are suitable for a variety of single-cell assays such as droplet-based methods like 10x Genomics Chromium and hybridization-based methods like SHARE-seq. Through sequencing we have verified that the resulting nuclei created through this protocol show a low percentage of mitochondrial RNA.

  • Loss of the Atrial Fibrillation-Related Gene, Zfhx3 , Results in Atrial Dilation and Arrhythmias

    by Heather S. Jameson, Alan Hanley, Matthew C. Hill, Ling Xiao, Jiangchuan Ye, Aneesh Bapat, Elsa Ronzier, Amelia Weber Hall, William J. Hucker, Sebastian Clauss, et al.

    Background: ZFHX3 (zinc finger homeobox 3), a gene that encodes a large transcription factor, is at the second-most significantly associated locus with atrial fibrillation (AF), but its function in the heart is unknown. This study aims to identify causative genetic variation related to AF at the ZFHX3 locus and examine the impact of Zfhx3 loss on cardiac function in mice. Methods: CRISPR-Cas9 genome editing, chromatin immunoprecipitation, and luciferase assays in pluripotent stem cell–derived cardiomyocytes were used to identify causative genetic variation related to AF at the ZFHX3 locus. Cardiac function was assessed by echocardiography, magnetic resonance imaging, electrophysiology studies, calcium imaging, and RNA sequencing in mice with heterozygous and homozygous cardiomyocyte-restricted Zfhx3 loss ( Zfhx3 Het and knockout, respectively). Human cardiac single-nucleus ATAC (assay for transposase-accessible chromatin)-sequencing data was analyzed to determine which genes in atrial cardiomyocytes are directly regulated by ZFHX3 . Results: We found single-nucleotide polymorphism (SNP) rs12931021 modulates an enhancer regulating ZFHX3 expression, and the AF risk allele is associated with decreased ZFHX3 transcription. We observed a gene-dose response in AF susceptibility with Zfhx3 knockout mice having higher incidence, frequency, and burden of AF than Zfhx3 Het and wild-type mice, with alterations in conduction velocity, atrial action potential duration, calcium handling and the development of atrial enlargement and thrombus, and dilated cardiomyopathy. Zfhx3 loss results in atrial-specific differential effects on genes and signaling pathways involved in cardiac pathophysiology and AF. Conclusions: Our findings implicate ZFHX3 as the causative gene at the 16q22 locus for AF, and cardiac abnormalities caused by loss of cardiac Zfhx3 are due to atrial-specific dysregulation of pathways involved in AF susceptibility. Together, these data reveal a novel and important role for Zfhx3 in the control of cardiac genes and signaling pathways essential for normal atrial function.


  • Open Access

    SHARE-seq protocol v2.2 v2

    by Amelia Hall, Gwyneth Torrecampo, Alexandra Ham, Cassandra White, Guillermo Barreto Corona, Eugenio Mattei, Charles B Epstein

    An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538

  • Open Access

    SHARE-seq protocol v2.2 v2

    by Amelia Hall, Gwyneth Torrecampo, Alexandra Ham, Cassandra White, Guillermo Barreto Corona, Eugenio Mattei, Charles B Epstein

    An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538

  • Open Access

    SHARE-seq protocol v2.2 v3

    by Amelia Hall, Gwyneth Torrecampo, Alexandra Ham, Cassandra White, Guillermo Barreto Corona, Eugenio Mattei, Charles B Epstein

    An updated version of the protocol SHARE-seq, as used by the Epigenomics Platform and Gene Regulation Observatory at the Broad Institute in the service of data production for the IGVF project. Link to the original paper and protocol here: https://www.sciencedirect.com/science/article/pii/S0092867420312538